Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Lumbar Plexus Block with Parasacral Block for Hip Replacement
NCT02161484Terminated
- Start
- Jan 2014
- Primary completion
- Jun 2014
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Randomised, single-blind trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain (2 arms). Primary endpoint: Numeric Rating Scale Pain Assessment at 48 hours. Started Jan 2014; status: terminated.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02161484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02161484.